Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,514
Closed -$504K 498
2025
Q4
$504K Buy
7,514
+327
+5% +$21.1K 0.03% 300
2025
Q3
$486K Sell
7,187
-410
-5% -$29.7K 0.03% 306
2025
Q2
$566K Buy
7,597
+3,788
+99% +$252K 0.04% 272
2025
Q1
$240K Buy
+3,809
New +$235K 0.02% 400

Other funds holding CTVA

Keel Point's CTVA Position: Q1 2026 in Review

Keel Point sold out of Corteva (CTVA) in Q1 2026, closing a stake of 7,514 shares — an estimated $504K sold.

Keel Point first reported a position in CTVA in Q1 2025 and held it in 4 quarters. The position peaked at $566K in Q2 2025. 1,476 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

  • Keel Point reported no remaining Corteva position as of Q1 2026 after selling out during the quarter.
  • Keel Point sold 7,514 Corteva shares in Q1 2026, an estimated $504K.
  • Keel Point first reported a position in Corteva in Q1 2025 and held it in 4 quarters.
  • Keel Point's Corteva position peaked at $566K in Q2 2025.
  • 1,476 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.